CRDOMay 10, 2026 at 2:34 PM UTCSemiconductors & Semiconductor Equipment

Credo's Hypergrowth Narrative Faces Reality Check

Read source article

What happened

A recent Seeking Alpha article argues Credo Technology's valuation ($192, ~98x P/E) is justified by 126% revenue growth and 69% gross margins, painting it as a core AI infrastructure play. However, the DeepValue report reveals that two customers account for 87% of quarterly revenue and contractual backlog is only $31.8 million, meaning growth rests on short-cycle purchase orders. The company's optical pivot, including the DustPhotonics acquisition, is essential to sustain the story but faces stiff competition from Broadcom's 3nm optical DSP. While the balance sheet is strong with $1.27 billion in cash, the current price leaves no margin of safety if hyperscaler programs pause or optical commercialization stalls. Investors should treat this as a momentum-driven narrative until diversification and optical milestones materialize over the next three to six months.

Implication

The DeepValue report rates CRDO a WAIT with a $150 attractive entry and $220 trim above. The stock's $192 price already embeds sustained AEC volume growth and a successful 1.6T optical transition. With no contractual backlog and extreme customer concentration, any sequential revenue decline or integration delay could trigger multiple compression. Investors should await the FQ4 FY26 report (due May 2026) to confirm revenue holds above $425 million and gross margin stabilizes near guided levels. A disciplined approach reduces risk of buying into a crowded AI narrative at peak momentum.

Thesis delta

The news article reinforces the bullish AI-interconnect theme but does not address the structural revenue fragility outlined in the DeepValue report. The core thesis shifts from 'buy the growth story' to 'wait for proof of diversification' given that the valuation leaves no room for error. The next two quarters will determine whether CRDO can broaden its customer base and deliver on optical commercialization, or risk a re-rating.

Confidence

Low